Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial.

Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Suwa S, Isawa T, Takenaka H, Ishikawa T, Yamada M, Wakatsuki T, Nozaki Y, Kitahara H, Kato R, Kawai R, Kobayashi Y, Ishii M, Goto Y, Ono K, Kimura T

Open source

DOI: 10.1161/jaha.123.034201
Published: 2024 Aug 6
Container: Journal of the American Heart Association
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/jaha.123.034201,
  title = {Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial.},
  author = {Natsuaki M and Watanabe H and Morimoto T and Yamamoto K and Obayashi Y and Nishikawa R and Ando K and Suwa S and Isawa T and Takenaka H and Ishikawa T and Yamada M and Wakatsuki T and Nozaki Y and Kitahara H and Kato R and Kawai R and Kobayashi Y and Ishii M and Goto Y and Ono K and Kimura T},
  year = {2024},
  journal = {Journal of the American Heart Association},
  doi = {10.1161/jaha.123.034201},
  url = {https://doi.org/10.1161/jaha.123.034201}
}

RIS

TY  - JOUR
TI  - Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial.
AU  - Natsuaki M
AU  - Watanabe H
AU  - Morimoto T
AU  - Yamamoto K
AU  - Obayashi Y
AU  - Nishikawa R
AU  - Ando K
AU  - Suwa S
AU  - Isawa T
AU  - Takenaka H
AU  - Ishikawa T
AU  - Yamada M
AU  - Wakatsuki T
AU  - Nozaki Y
AU  - Kitahara H
AU  - Kato R
AU  - Kawai R
AU  - Kobayashi Y
AU  - Ishii M
AU  - Goto Y
AU  - Ono K
AU  - Kimura T
PY  - 2024
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.123.034201
UR  - https://doi.org/10.1161/jaha.123.034201
ER  -

APA

M, N., H, W., T, M., K, Y., Y, O., R, N., K, A., S, S., T, I., H, T., T, I., M, Y., T, W., Y, N., H, K., R, K., R, K., Y, K., M, I., Y, G., K, O., & T, K. (2024). Aspirin-Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT-3 Trial.. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.034201

Source records

pubmed · retrieved 2026-09-26T20:19:41.982Z
europe-pmc · retrieved 2026-09-26T20:19:41.994Z
doaj · retrieved 2026-09-26T20:19:42.000Z